CVC Capital Partners has reportedly snapped up stake in firms involved in running the computer system behind Covid-19 jabs
A private equity firm has sought to cash in on the coronavirus vaccine rollout by investing in businesses underpinning the effort.
CVC Capital Partners has reportedly snapped up a majority stake in Kent-based System C, and a minority stake in Milton Keynes-based Graphnet Health from US rival Symphony Technology.
The two healthcare technology firms are involved in running the computer system powering the rollout of Covid-19 jabs.
System C and Graphnet were valued at less than £500million combined under the deal, according to the Financial Times. But Luxembourg-based CVC is hoping that their values will soon rocket.
System C employs more than 500 people and provides digital health records services to the NHS.
Graphnet provides software for record-keeping, care planning and data analysis.